Notification of dealings by a director/PDMR | 09-Sep-2025 | 07:00 | RNS |
Therapeutic development agreement with Invizius | 02-Sep-2025 | 07:00 | RNS |
Block Listing Interim Review | 28-Aug-2025 | 07:00 | RNS |
Biomarker Discovery Service Launch | 27-Aug-2025 | 07:00 | RNS |
Update on licensing and development progress | 22-Aug-2025 | 07:00 | RNS |
Exercise of warrants | 19-Aug-2025 | 07:00 | RNS |
Holding(s) in Company | 18-Aug-2025 | 15:44 | RNS |
Contract extension with global pharma partner | 18-Aug-2025 | 07:00 | RNS |
Holding(s) in Company | 07-Aug-2025 | 17:24 | RNS |
Holding(s) in Company | 05-Aug-2025 | 08:05 | RNS |
Trading Update | 31-Jul-2025 | 07:00 | RNS |
Holding(s) in Company | 28-Jul-2025 | 12:25 | RNS |
Result of General Meeting | 24-Jul-2025 | 11:48 | RNS |
Additional work commissioned by Unilever | 21-Jul-2025 | 07:00 | RNS |
Issue of Equity in lieu of Non-Exec Director Fees | 18-Jul-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 0.93p |
Change Today | 0.20p |
% Change | 27.59 % |
52 Week High | 1.30 |
52 Week Low | 0.21 |
Volume | 18,800,286 |
Shares Issued | 2,696.98m |
Market Cap | £24.95m |
Beta | 0.07 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:08 | 1,732,433 @ 0.94p |
15:58 | 1,000,000 @ 0.91p |
15:34 | 1,086,210 @ 0.92p |
16:26 | 18,891 @ 0.91p |
16:24 | 14,066 @ 0.91p |
CEO | Arron Tolley |
CFO | Andrew Rapson |
You are here: research